Structures of small molecules bound to RNA repeat expansions that cause Huntington's disease-like 2 and myotonic dystrophy type 1
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | 2D NOESY | 0.4 mM RNA (5'-R(*GP*AP*CP*AP*GP*CP*UP*GP*CP*UP*GP*UP*C)-3'), 0.6 mM 4-[(3-methoxyphenyl)amino]-2-methylquinoline-6-carboximidamide, 5 mM potassium, 0.5 mM EDTA | 100% D2O | 5 mM | 6.0 | 1 atm | 308 | Bruker AVANCE III 900 |
2 | 2D DQF-COSY | 0.4 mM RNA (5'-R(*GP*AP*CP*AP*GP*CP*UP*GP*CP*UP*GP*UP*C)-3'), 0.6 mM 4-[(3-methoxyphenyl)amino]-2-methylquinoline-6-carboximidamide, 5 mM potassium, 0.5 mM EDTA | 100% D2O | 5 mM | 6.0 | 1 atm | 308 | Bruker AVANCE III 900 |
3 | 2D NOESY | 0.4 mM RNA (5'-R(*GP*AP*CP*AP*GP*CP*UP*GP*CP*UP*GP*UP*C)-3'), 0.6 mM 4-[(3-methoxyphenyl)amino]-2-methylquinoline-6-carboximidamide, 5 mM potassium, 0.5 mM EDTA | 95% H2O/5% D2O | 5 mM | 6.0 | 1 atm | 278 | Bruker AVANCE III HD 800 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | AVANCE III | 900 |
2 | Bruker | AVANCE III HD | 800 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
simulated annealing | Amber |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | structures with the least restraint violations |
Conformers Calculated Total Number | 100 |
Conformers Submitted Total Number | 20 |
Representative Model | 1 (fewest violations) |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | collection | TopSpin | Bruker Biospin | |
2 | structure calculation | Amber | 20 | Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, and Kollman |
3 | data analysis | NMRFAM-SPARKY | 1.470 | Goddard TD & Kneller DG (2008) SPARKY 3. University of California, San Francisco. |